AxoGen, Inc. (NASDAQ:AXGN) Q1 2020 Earnings Conference Call May 6, 2020 4:30 AM ET Company Participants Karen Zaderej - Chairman, President, and CEO Peter J. Mariani - CFO Conference Call Participants Unidentified Analyst - SVB Leerink Rajbir Denhoy - Jefferies David Turkaly - JMP Securities Unidentified Analyst - Canaccord Genuity Corp. Operator Greetings and welcome to the AxoGen First Quarter 2020 Financial Results Conference Call. At this time all participants are in a listen-only mode. A question-and- ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to______________ Commission file number: 001-36046 Axogen, Inc. (Exact Name of Registrant as Specified in Its Charter) | --- | ...

AxoGen, Inc. (NASDAQ:AXGN) Q4 2019 Earnings Conference Call February 24, 2020 4:30 PM ET Company Participants Peter Mariani - Chief Financial Officer Karen Zaderej - Chairman, President and Chief Executive Officer Conference Call Participants Rajbir Denhoy - Jefferies LLC Richard Newitter - SVB Leerink LLC Daniel Stauder - JMP Securities LLC Samuel Brodovsky - BTIG, LLC Kyle Rose - Canaccord Genuity Operator Greetings. Welcome to the AxoGen’s Fourth Quarter and Full-Year 2019 Financial Results Conference Ca ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended DECEMBER 31, 2019 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from TO Commission File Number: 001-36046 AXOGEN, INC. (Exact name of registrant as specified in its charter) MINNESOTA 41-1301878 (State or other jur ...

AxoGen, Inc. (NASDAQ:AXGN) Q3 2019 Earnings Conference Call November 6, 2019 4:30 PM ET Company Participants Pete Mariani - Chief Financial Officer Karen Zaderej - Chairman, Chief Executive Officer & President Conference Call Participants Jaime Lynn - SVB Leerink Raj Denhoy - Jefferies Operator Welcome to the AxoGen Inc. Third Quarter 2019 Fiscal Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Ins ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to______________ Commission file number: 001-36046 Axogen, Inc. (Exact Name of Registrant as Specified in Its Charter) | -- ...